{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:19:21Z","timestamp":1790662761611,"version":"4.1.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Cactus Life Sciences"},{"DOI":"10.13039\/100007819","name":"Allergan Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AbbVie company"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The role of ATX-101 in submental fat reduction has been well documented; however, its applicability across multiple anatomic areas is to be explored.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The authors sought to describe the experience with ATX-101 subcutaneous injections for body and jawline contouring and evaluate its safety.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This single-arm, single-center observational study included 201 patients who underwent injection adipocytolysis with ATX-101 (area-adjusted dose of 2 mg\/cm2) in the jowl, abdomen (upper\/lower), thigh (inner\/outer\/banana roll), arm, anterior periaxillary fat, back (lower\/upper\/nape\/lipoma), knee (anterior\/medial), chest, and\/or neck. The number of treatment sessions, treatment volumes, doses, injections required for each anatomic area, and associated adverse events were recorded.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The mean number of treatment sessions conducted was 1.8. Multiple sessions were common for the jowl (mean: 2.0 and mean volume administered varied significantly between persons receiving 1 or multiple sessions [P = 0.005]). The mean volume and mean number of injections per session were highest in the chest (84.7 mL and 423.5, respectively) and lowest in the jowl (0.8 mL and 4.6, respectively). The chest (0.2 mL) and nape (0.2 mL) received the highest mean ATX-101 dose per injection site per session, whereas the inner thigh (0.11 mL) and upper back (0.11 mL) received the least. Adverse events observed were localized to the injection site. All patients experienced edema after each session, whereas numbness, tenderness, bruising, and paresis were experienced by 99.6%, 94.2%, 33.1%, and 2.6% of patients, respectively. Alopecia was not observed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>ATX-101 was well tolerated for body and jawline contouring.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Level of Evidence: 4<\/jats:title>\n                  <jats:p\/>\n               <\/jats:sec>","DOI":"10.1093\/asj\/sjac285","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T15:17:16Z","timestamp":1667488636000},"page":"470-483","source":"Crossref","is-referenced-by-count":3,"title":["Injection Adipocytolysis for Body and Jawline Contouring: Real-World Experience and Treatment Considerations"],"prefix":"10.1093","volume":"43","author":[{"given":"Sachin M","family":"Shridharani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace M","family":"Tisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MacKenzie L","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,11,3]]},"reference":[{"issue":"4","key":"2023070705134956700_sjac285-B1","first-page":"285","article-title":"Update on noninvasive body contouring techniques","volume":"101","author":"Rzepecki","year":"2018","journal-title":"Cutis"},{"key":"2023070705134956700_sjac285-B2","doi-asserted-by":"publisher","DOI":"10.1093\/asj\/sjac116"},{"issue":"4","key":"2023070705134956700_sjac285-B3","doi-asserted-by":"publisher","first-page":"e36727","DOI":"10.5812\/ijem.36727","article-title":"Review of the mechanisms and effects of noninvasive body contouring devices on cellulite and subcutaneous fat","volume":"14","author":"Alizadeh","year":"2016","journal-title":"Int J Endocrinol Metab"},{"key":"2023070705134956700_sjac285-B4","doi-asserted-by":"publisher","first-page":"4701481","DOI":"10.1155\/2017\/4701481","article-title":"The effects of low-intensity ultrasound on fat reduction of rat model","volume":"2017","author":"Zhou","year":"2017","journal-title":"Biomed Res Int"},{"key":"2023070705134956700_sjac285-B5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/CCID.S125580","article-title":"The role of inflammation in adipocytolytic nonsurgical esthetic procedures for body contouring","volume":"10","author":"Pereira","year":"2017","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"12","key":"2023070705134956700_sjac285-B6","first-page":"44","article-title":"Injection adipolysis: mechanisms, agents, and future directions","volume":"9","author":"Kamalpour","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"issue":"11","key":"2023070705134956700_sjac285-B7","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.36849\/jdd.3936","article-title":"Deoxycholic acid (ATX-101) for fat reduction","volume":"20","author":"Gupta","year":"2021","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"2023070705134956700_sjac285-B8","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/j.1524-4725.2010.01566.x","article-title":"Tissue-selective effects of injected deoxycholate","volume":"36","author":"Thuangtong","year":"2010","journal-title":"Dermatol Surg"},{"key":"2023070705134956700_sjac285-B9","doi-asserted-by":"publisher","first-page":"e1155","DOI":"10.1097\/GOX.0000000000001155","article-title":"Noninvasive submental fat compartment treatment","volume":"4","author":"Shamban","year":"2016","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"3","key":"2023070705134956700_sjac285-B10","first-page":"279","article-title":"A phase I safety and pharmacokinetic study of ATX-101: injectable, synthetic deoxycholic acid for submental contouring","volume":"14","author":"Walker","year":"2015","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"2023070705134956700_sjac285-B11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/DSS.0000000000000578","article-title":"REFINE-1, a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial with ATX-101, an injectable drug for submental fat reduction","volume":"42","author":"Jones","year":"2016","journal-title":"Dermatol Surg"},{"issue":"11","key":"2023070705134956700_sjac285-B12","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/asj\/sjab100","article-title":"Improvements in submental contour up to 3 years after ATX-101: efficacy and safety follow-up of the phase 3 REFINE trials","volume":"41","author":"Humphrey","year":"2021","journal-title":"Aesthet Surg J"},{"issue":"8","key":"2023070705134956700_sjac285-B13","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/lsm.23397","article-title":"Single treatment protocol with microneedle fractional radiofrequency for treatment of body skin laxity and fat deposits","volume":"53","author":"Alexiades","year":"2021","journal-title":"Lasers Surg Med"},{"issue":"1","key":"2023070705134956700_sjac285-B14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/DSS.0000000000001869","article-title":"Jowl reduction with deoxycholic acid","volume":"46","author":"Montes","year":"2020","journal-title":"Dermatol Surg"},{"issue":"4","key":"2023070705134956700_sjac285-B15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.12968\/joan.2019.8.Sup1.34","article-title":"Non-surgical body contouring: an ever-expanding area of medical aesthetics","volume":"6","author":"Young","year":"2017","journal-title":"J. Aesthet Nurs"},{"issue":"5","key":"2023070705134956700_sjac285-B16","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1517\/14656566.2015.1019465","article-title":"ATX-101 for reduction of submental fat","volume":"16","author":"Wollina","year":"2015","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"2023070705134956700_sjac285-B17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/bjd.12695","article-title":"Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study","volume":"170","author":"Rzany","year":"2014","journal-title":"Br J Dermatol"},{"issue":"12","key":"2023070705134956700_sjac285-B18","doi-asserted-by":"publisher","first-page":"NP495","DOI":"10.1093\/asj\/sjz067","article-title":"Injection of an adipocytolytic agent for reduction of excess periaxillary fat","volume":"39","author":"Shridharani","year":"2019","journal-title":"Aesthet Surg J"},{"issue":"10","key":"2023070705134956700_sjac285-B19","doi-asserted-by":"publisher","first-page":"e2459","DOI":"10.1097\/GOX.0000000000002459","article-title":"Novel surface anatomic landmarks of the jowl to guide treatment with ATX-101","volume":"7","author":"Shridharani","year":"2019","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"2","key":"2023070705134956700_sjac285-B20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2147\/ciia.2006.1.2.115","article-title":"Aging and cosmetic enhancement","volume":"1","author":"Honigman","year":"2006","journal-title":"Clin Interv Aging"},{"key":"2023070705134956700_sjac285-B21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/1744-7941.12137","article-title":"Cosmetic facial surgery: the influence of self-esteem on job satisfaction and burnout","volume":"55","author":"Kalus","year":"2017","journal-title":"Asia Pac J Hum Resour"},{"issue":"Suppl 2","key":"2023070705134956700_sjac285-B22","doi-asserted-by":"publisher","first-page":"S225","DOI":"10.1097\/DSS.0000000000001306","article-title":"ATX-101 (deoxycholic acid injection) treatment in men: insights from our clinical experience","volume":"43","author":"Shridharani","year":"2017","journal-title":"Dermatol Surg"},{"issue":"7","key":"2023070705134956700_sjac285-B23","doi-asserted-by":"publisher","first-page":"e3668","DOI":"10.1097\/GOX.0000000000003668","article-title":"Best clinical practices with ATX-101 for submental fat reduction: patient-related factors and physician considerations","volume":"9","author":"Teller","year":"2021","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"9","key":"2023070705134956700_sjac285-B24","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/asj\/sjy008","article-title":"Efficacy and safety of ATX-101 by treatment session: pooled analysis of data from the phase 3 REFINE trials","volume":"38","author":"Dayan","year":"2018","journal-title":"Aesthet Surg J"},{"issue":"11","key":"2023070705134956700_sjac285-B25","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1097\/DSS.0000000000001484","article-title":"Reduction of submental fat continues beyond 28 days after ATX-101 treatment: results from a post hoc analysis","volume":"44","author":"Dover","year":"2018","journal-title":"Dermatol Surg"},{"issue":"6","key":"2023070705134956700_sjac285-B26","doi-asserted-by":"publisher","first-page":"e1794","DOI":"10.1097\/GOX.0000000000001794","article-title":"Evaluation of safe and effectiveness of an injectable solution acid deoxycholic based for reduction of localized adiposities","volume":"6","author":"Amore","year":"2018","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"5","key":"2023070705134956700_sjac285-B27","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/DSS.0000000000002092","article-title":"ATX-101 (deoxycholic acid injection) leads to clinically meaningful improvement in submental fat: final data from CONTOUR","volume":"46","author":"Behr","year":"2020","journal-title":"Dermatol Surg"},{"issue":"7","key":"2023070705134956700_sjac285-B28","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.3390\/ijerph18073845","article-title":"Effect of an endurance and strength mixed circuit training on regional fat thickness: the quest for the \u201cspot reduction\u201d","volume":"18","author":"Paoli","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2023070705134956700_sjac285-B29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fendo.2019.00137","article-title":"The impact of aging on adipose function and adipokine synthesis","volume":"10","author":"Mancuso","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2023070705134956700_sjac285-B30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/9781439802724","volume-title":"Cellulite: Pathophysiology and Treatment","author":"Goldman","year":"2010","edition":"2nd ed"},{"issue":"4","key":"2023070705134956700_sjac285-B31","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1097\/PRS.0000000000006680","article-title":"Improvement in jowl fat following ATX-101 treatment: results from a single-site study","volume":"145","author":"Shridharani","year":"2020","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"2023070705134956700_sjac285-B32","doi-asserted-by":"publisher","first-page":"995e","DOI":"10.1097\/PRS.0000000000006299","article-title":"Novel expanded safe zone for reduction of submental fullness with ATX-101 injection","volume":"144","author":"Shridharani","year":"2019","journal-title":"Plast Reconstr Surg"},{"issue":"12","key":"2023070705134956700_sjac285-B33","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1111\/jdv.12377","article-title":"Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study","volume":"28","author":"Ascher","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Aesthetic Surgery Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/asj\/advance-article-pdf\/doi\/10.1093\/asj\/sjac285\/47768275\/sjac285.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/asj\/article-pdf\/43\/4\/470\/50835091\/sjac285.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/asj\/article-pdf\/43\/4\/470\/50835091\/sjac285.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T05:14:46Z","timestamp":1688706886000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/asj\/article\/43\/4\/470\/6795018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,3]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,11,3]]},"published-print":{"date-parts":[[2023,3,15]]}},"URL":"https:\/\/doi.org\/10.1093\/asj\/sjac285","relation":{},"ISSN":["1090-820X","1527-330X"],"issn-type":[{"value":"1090-820X","type":"print"},{"value":"1527-330X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4,1]]},"published":{"date-parts":[[2022,11,3]]}}}